Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06333938
Other study ID # 01968
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date June 2024
Est. completion date June 2025

Study information

Verified date March 2024
Source Durham VA Medical Center
Contact Karthik Raghunathan, MD MPH
Phone 2158507220
Email karthik.raghunathan@duke.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study aims to assess the effectiveness of NSS2-Bridge in postoperative pain management in comparison to Battlefield Acupuncture (BFA).


Description:

There is an urgent need for effective, safe, and low-cost nonpharmacologic treatments for postoperative pain. This study aims to measure the implementation and effectiveness of Masimo Bridge versus Battlefield Acupuncture (BFA). The Bridge device requires less provider training and delivers treatment for 5 days whereas BFA requires provider training and maintenance of competence, and the duration of effects are unknown. We expect that implementation and effectiveness outcomes will be similar or will favor the Bridge device. Patients from the Durham Veterans Affairs Medical Center (Durham VAMC) scheduled to undergo total knee arthroplasty (TKA) will be eligible to participate in this study. A sample of 60 veterans will studied over six months. We will offer BFA versus Bridge on alternate months, and recruitment will end when 40 patients have received the Bridge and at least 20 have received BFA.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 2025
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Veterans Scheduled to undergo knee join replacement (TKA) Exclusion Criteria: - Risk of Bleeding - Patients with cardiac pacemakers - Patients with psoriasis vulgaris

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bridge
Percutaneous Nerve Field Stimulation using a disposable battery operated and device, approved by the FDA for the treatment of clinical symptoms related to opioid withdrawal.
BFA
BFA is an auricular acupuncture technique (developed within the VA/ DoD health systems) delivered by providers using 1mm acupuncture needles.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Durham VA Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Pain and Pain Interference assessed among patients using the Defense veterans pain rating scale 2.0 The Defense and Veterans Pain Rating Scale 2.0 utilizes a numerical rating scale enhanced by functional word descriptors, color coding, and pictorial facial expressions matched to pain levels. Four supplemental questions measure how much pain: a) interferes with usual activity, b) interferes with sleep, c) affects mood and d) contributes to stress. The scale for each assessment ranges from 0-10. Three assessments will occur each day. The daily average values will be compared at each time point. Higher Scores represent worse outcomes. Each day from Postoperative Day 0 to Day 5.
Primary Heart Rate Variability among Patients as assessed using time and frequency domain analysis of the heart rate. Heart rate variability represents the change in the time interval in milliseconds between successive heartbeats. It is a measure of input to the heart from both sympathetic and parasympathetic branches of the nervous system. Increased heart rate variability is the better outcome. Each day (over 8-hour periods, 7pm and 7am) from 5 days before surgery to postoperative day 5.
Primary Implementation of Treatment among Patients as assessed by the Acceptability of Intervention, Appropriateness of Intervention, and Feasibility of Intervention Measures. The Acceptability of Intervention measure, Appropriateness of Intervention measure, and Feasibility of Intervention Measure will be used. Each of these three tools is a 4-item questionnaire that has been validated as a distinct and strong measure of implementation success. Scale values for each measure range from 1-5. The average of the three measures will be computed and compared at each time point. Higher scores represent better outcomes. Measurement will be at three points: within the 5 day period before surgery; on the day of Surgery; and on postoperative day 5.
Primary Fidelity of Treatment among Patients as assessed by a Fidelity Checklist Fidelity, the degree to which an intervention was implemented as it was intended by the developers, will be measured using a fidelity instrument with three domains: adherence (adherence to each component of treatment, scale 1- 5), participant responsiveness (measured on the treatment expectation questionnaire scale 0-10), and dosage (scale 1-5). Higher scores are better. We will compare the average scores overall, and in each domain. Each day from Postoperative Day 0 to Day 5.
Primary Implementation of Treatment among Providers as assessed by the Acceptability of Intervention, Appropriateness of Intervention, and Feasibility of Intervention Measures. The Acceptability of Intervention measure, Appropriateness of Intervention measure, and Feasibility of Intervention Measure will be used. Each of these three tools is a 4-item questionnaire that has been validated as a distinct and strong measure of implementation success. Scale values for each measure range from 1-5. The average of the three measures will be computed and compared. Higher scores represent better outcomes. On the day of surgery or within 1-day after.
Primary Fidelity of Treatment among Providers as assessed by a Fidelity Checklist Fidelity, the degree to which an intervention was implemented as it was intended by the developers, will be measured using a fidelity instrument with two domains: adherence (adherence to each component of treatment, scale 1- 5), and participant responsiveness (measured on the treatment expectation questionnaire scale 0-10). Higher scores are better. We will compare the average scores overall, and in each domain. On the day of surgery or within 1-day after.
Secondary Amount of Opioid medication received by patients assessed in average daily oral morphine equivalents. The amount of opioid analgesic medications received by patients as recorded in the electronic health record (inpatient setting) or as reported by patients (outpatient setting) will be summarized each day and reported in daily oral morphine equivalents. The total amount from postoperative day 0 to day 5, and the average daily oral morphine equivalents will be measured for comparisons. Higher amounts represent worse outcomes. Each day from Postoperative Day 0 to Day 5.
Secondary Quality of Recovery among patients as measured using the Quality-of-Recovery 40 tool. The Quality-of-Recovery 40 tool is a 40-item questionnaire, with each question graded on a five-point Likert scale. Scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). Assessment will occur preoperatively on the day of surgery (baseline value) and each day from Postoperative Day 0 to 5. The difference between the baseline and the value each day will be compared. Preoperative on the day of surgery, and each day from Postoperative Day 0 to Day 5.
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A
Completed NCT03355547 - Observation of Atelectasis Using Lung Ultrasonography in Children Undergoing General Anesthesia: the Cohort Study for Evaluation of the Relationship Between the Incidence and Severity of Upper Respiratory Tract Infection and the Magnitude of Anesthesia-induced Atelectasis